1. Key Insights 2. Disease Background and Overview: Narcolepsy 2.1. Introduction 2.2. Signs and Symptoms 2.3. Complications 2.4. Pathophysiology 2.5. Etiology 2.6. Risk Factors 2.7. Diagnosis 2.8. Treatment 3. Epidemiology and Patient Population 3.1. Key Findings 3.2. Population and Forecast Parameters 4. 7MM Total Prevalent Patient Population of Narcolepsy 4.1. United States 4.1.1. Prevalent Patient Population of Narcolepsy in the United States 4.1.2. Narcolepsy with and without Cataplexy Cases 4.1.3. Prevalent Cases by Clinical Manifestation 4.1.4. Diagnosed Cases of Narcolepsy 4.1.5. Age-Specific Diagnosed Cases of Narcolepsy 4.2. Germany 4.2.1. Prevalent Population of Narcolepsy 4.2.2. Narcolepsy cases with and without Cataplexy 4.2.3. Prevalent Cases by Clinical Manifestation 4.2.4. Diagnosed Cases of Narcolepsy 4.2.5. Age-Specific Diagnosed Cases of Narcolepsy 4.3. France 4.3.1. Prevalent Population of Narcolepsy 4.3.2. Narcolepsy cases with and without Cataplexy 4.3.3. Prevalent Cases by Clinical Manifestation 4.3.4. Diagnosed Cases of Narcolepsy 4.3.5. Age-Specific Diagnosed Cases of Narcolepsy 4.4. Italy 4.4.1. Prevalent Population of Narcolepsy in Italy 4.4.2. Narcolepsy cases with and without Cataplexy 4.4.3. Prevalent Cases by Clinical Manifestation 4.4.4. Diagnosed Cases of Narcolepsy 4.4.5. Age-Specific Diagnosed Cases of Narcolepsy 4.5. Spain 4.5.1. Prevalent Population of Narcolepsy 4.5.2. Narcolepsy cases with and without Cataplexy 4.5.3. Prevalent Cases by Clinical Manifestation 4.5.4. Diagnosed Cases of Narcolepsy 4.5.5. Age-Specific Diagnosed Cases of Narcolepsy 4.6. United Kingdom 4.6.1. Prevalent Cases of Narcolepsy 4.6.2. Narcolepsy cases with and without Cataplexy 4.6.3. Prevalent Cases by Clinical Manifestation 4.6.4. Diagnosed Cases of Narcolepsy 4.6.5. Age-Specific Diagnosed Cases of Narcolepsy 4.7. Japan 4.7.1. Prevalent Population of Narcolepsy 4.7.2. Narcolepsy cases with and without Cataplexy 4.7.3. Prevalent Cases by Clinical Manifestation 4.7.4. Diagnosed Cases of Narcolepsy 4.7.5. Age-Specific Diagnosed Cases of Narcolepsy 5. Market Drivers 6. Market Barriers 7. Appendix 8. Report Methodology 8.1. Sources Used 9. Capabilities 10. Disclaimer 11. About

Table 1 Total Prevalent Patient Population of Narcolepsy in the 7MM (2016-2028) Table 2 Prevalent Cases of Narcolepsy in the United States (2016-2028) Table 3 Narcolepsy with and without Cataplexy Cases in the United States (2016-2028) Table 4 Prevalent Cases of Narcolepsy by Clinical Manifestations in the United States (2016-2028) Table 5 Diagnosed Cases of Narcolepsy in the United States (2016-2028) Table 6 Age-Specific Diagnosed Cases of Narcolepsy in United States (2016-2028) Table 7 Prevalent Cases of Narcolepsy in Germany (2016-2028) Table 8 Narcolepsy with and without Cataplexy Cases in Germany (2016-2028) Table 9 Prevalent Cases of Narcolepsy by Clinical Manifestations in Germany (2016-2028) Table 10 Diagnosed Cases of Narcolepsy in Germany (2016-2028) Table 11 Age-Specific Diagnosed Cases of Narcolepsy in Germany (2016-2028) Table 12 Prevalent Cases of Narcolepsy in France (2016-2028) Table 13 Narcolepsy with and without Cataplexy cases in France (2016-2028) Table 14 Prevalent Cases of Narcolepsy by Clinical Manifestations in France (2016-2028) Table 15 Diagnosed Cases of Narcolepsy in France (2063-2028) Table 16 Age-Specific Diagnosed Cases of Narcolepsy in France (2016-2028) Table 17 Prevalent Population of Narcolepsy in Italy (2016-2028) Table 18 Narcolepsy with and without Cataplexy cases in Italy (2016-2028) Table 19 Prevalent Cases of Narcolepsy by Clinical Manifestations in Italy (2016-2028) Table 20 Diagnosed Cases of Narcolepsy in Italy (2016-2028) Table 21 Age-Specific Diagnosed Cases of Narcolepsy in Italy (2016-2028) Table 22 Prevalent Cases of Narcolepsy in Spain (2016-2028) Table 23 Narcolepsy with and without Cataplexy Cases in Spain (2016-2028) Table 24 Prevalent Cases of Narcolepsy by Clinical Manifestations in Spain (2016-2028) Table 25 Diagnosed Cases of Narcolepsy in Spain (2016-2028) Table 26 Age-Specific Diagnosed Cases of Narcolepsy in Spain (2016-2028) Table 27 Prevalent Cases of Narcolepsy in the United Kingdom (2016-2028) Table 28 Narcolepsy with and without Cataplexy cases in the United Kingdom (2016-2028) Table 29 Prevalent Cases of Narcolepsy by Clinical Manifestations in United Kingdom (2016-2028) Table 30 Diagnosed Cases of Narcolepsy in the United Kingdom (2016-2028) Table 31 Age-Specific Diagnosed Cases of Narcolepsy in the United Kingdom (2016-2028) Table 32 Prevalent Cases of Narcolepsy in Japan (2016-2028) Table 33 Narcolepsy with and without Cataplexy cases in Japan (2016-2028) Table 34 Prevalent Cases of Narcolepsy by Clinical Manifestations in Japan (2016-2028) Table 35 Diagnosed Cases of Narcolepsy in Japan (2016-2028) Table 36 Age-Specific Diagnosed Cases of Narcolepsy in Japan (2016-2028) Figure 1: Complications of Narcolepsy Figure 2: Pathophysiology of Narcolepsy Figure 3: Prevalent Cases of Narcolepsy in the United States (2016-2028) Figure 4: Narcolepsy with and without Cataplexy Cases in the United States (2016-2028) Figure 5: Prevalent Cases of Narcolepsy by Clinical Manifestations in the United States (2016-2028) Figure 6: Diagnosed Cases of Narcolepsy in the United States (2016-2028) Figure 7: Age-Specific Diagnosed Cases of Narcolepsy in the United States (2016-2028) Figure 8:Prevalent Cases of Narcolepsy in Germany (2016-2028) Figure 9: Narcolepsy with and without Cataplexy Cases in Germany (2016-2028) Figure 10: Prevalent Cases of Narcolepsy by Clinical Manifestations in Germany (2016-2028) Figure 11: Diagnosed Cases of Narcolepsy in Germany (2016-2028) Figure 12: Age-Specific Diagnosed Cases of Narcolepsy in Germany (2016-2028) Figure 13: Prevalent Cases of Narcolepsy in France (2016-2028) Figure 14: Narcolepsy with and without Cataplexy cases in France (2016-2028) Figure 15: Prevalent Cases of Narcolepsy by Clinical Manifestations in France (2016-2028) Figure 16: Diagnosed Cases of Narcolepsy in France (2016-2028) Figure 17: Age-Specific Diagnosed Cases of Narcolepsy in France (2016-2028) Figure 18: Prevalent Population of Narcolepsy in Italy (2016-2028) Figure 19: Narcolepsy with and without Cataplexy cases in Italy (2016-2028) Figure 20: Prevalent Cases of Narcolepsy by Clinical Manifestations in Italy (2016-2028) Figure 21: Diagnosed Cases of Narcolepsy in Italy (2016-2028) Figure 22: Age-Specific Diagnosed Cases of Narcolepsy in Italy (2016-2028) Figure 23: Prevalent Cases of Narcolepsy in Spain (2016-2028) Figure 24: Narcolepsy with and without Cataplexy Cases in Spain (2016-2028) Figure 25: Prevalent Cases of Narcolepsy by Clinical Manifestations in Spain (2016-2028) Figure 26: Diagnosed Cases of Narcolepsy in Spain (2016-2028) Figure 27: Age-Specific Diagnosed Cases of Narcolepsy in Spain (2016-2028) Figure 28: Prevalent Cases of Narcolepsy in the United Kingdom (2016-2028) Figure 29: Narcolepsy with and without Cataplexy cases in the United Kingdom (2016-2028) Figure 30: Prevalent Cases of Narcolepsy by Clinical Manifestations in the United Kingdom (2016-2028) Figure 31: Diagnosed Cases of Narcolepsy in the United Kingdom (2016-2028) Figure 32: Age-Specific Diagnosed Cases of Narcolepsy in the United Kingdom (2016-2028) Figure 33: Prevalent Population of Narcolepsy in Japan (2016-2028) Figure 34: Narcolepsy with and without Cataplexy cases in Japan (2016-2028) Figure 35: Prevalent Cases of Narcolepsy by Clinical Manifestations in Japan (2016-2028) Figure 36: Total Prevalent Population of Narcolepsy in Japan (2016-2028) Figure 37: Age-Specific Diagnosed Cases of Narcolepsy in Japan (2016-2028)